Utkast til Kosthåndboken - Napha

the International Consensus Guideline Committee. Clin Nutr 2010;29(2):151-3.
126. Hagen KB, Byfuglien MG, Falzon L, Olsen SU, Smedslund G. Dietary interventions for rheumatoid
arthritis. Cochrane Database Syst Rev 2009;(1):CD006400.
127. Galarraga B, Ho M, Youssef HM, Hill A, McMahon H, Hall C, et al. Cod liver oil (n-3 fatty acids) as an
non-steroidal anti-inflammatory drug sparing agent in rheumatoid arthritis. Rheumatology (Oxford)
2008;47(5):665-9.
128. Goldberg RJ, Katz J. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid
supplementation for inflammatory joint pain. Pain 2007;129(1-2):210-23.
129. Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Alcohol intake and risk of incident gout in men:
a prospective study. Lancet 2004;363(9417):1277-81.
130. Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Purine-rich foods, dairy and protein intake, and
the risk of gout in men. N Engl J Med 2004;350(11):1093-103.
131. Johannessen A, Omenaas ER, Bakke PS, Gulsvik A. Implications of reversibility testing on prevalence
and risk factors for chronic obstructive pulmonary disease: a community study. Thorax 2005;60(10):842-
7.
132. Prescott E, Almdal T, Mikkelsen KL, Tofteng CL, Vestbo J, Lange P. Prognostic value of weight change
in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J
2002;20(3):539-44.
133. Weekes CE, Emery PW, Elia M. Dietary counselling and food fortification in stable COPD: a randomised
trial. Thorax 2009;64(4):326-31.
134. Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of
chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157(6 Pt 1):1791-7.
135. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis,
management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am
J Respir Crit Care Med 2007;176(6):532-55.
136. Anker SD, John M, Pedersen PU, Raguso C, Cicoira M, Dardai E, et al. ESPEN Guidelines on Enteral
Nutrition: Cardiology and pulmonology. Clin Nutr 2006;25(2):311-8.
137. Pinnock CB, Arney WK. The milk-mucus belief: sensory analysis comparing cow's milk and a soy
placebo. Appetite 1993;20(1):61-70.
138. Wuthrich B, Schmid A, Walther B, Sieber R. Milk consumption does not lead to mucus production or
occurrence of asthma. J Am Coll Nutr 2005;24(6 Suppl):547S-55S.
139. Midgaard C, Storrøsten O-T. Cystisk fibrose: diagnostikk og generell informasjon [nettdokument].
[oppdatert 25 Feb 2011; lest 22 Jul 2011]. Tilgjengelig fra: http://www.oslouniversitetssykehus.no/fagfolk/temasider/Sider/cystisk-fibrose-diagnostikk-og-generell-informasjon.aspx
140. Sinaasappel M, Stern M, Littlewood J, Wolfe S, Steinkamp G, Heijerman HG, et al. Nutrition in patients
with cystic fibrosis: a European Consensus. J Cyst Fibros 2002;1(2):51-75.
141. Ramsey BW, Farrell PM, Pencharz P. Nutritional assessment and management in cystic fibrosis: a
consensus report. The Consensus Committee. Am J Clin Nutr 1992;55(1):108-16.
142. Foltynie T, Lewis S, Barker R. Parkinson's disease: your questions answered. Edinburgh: Churchill
Livingstone; 2003.
143. Pare S, Barr SI, Ross SE. Effect of daytime protein restriction on nutrient intakes of free-living
Parkinson's disease patients. Am J Clin Nutr 1992;55(3):701-7.
144. Vilming ST. Diettbehandling ved Parkinsons sykdom. Tidsskr Nor Lægeforen 1995;115(10):1244-7.
227